Kethu Sripathi R
Department of Medicine, Division of Gastroenterology, Brown Medical School, Providence, RI 02912, USA.
J Clin Gastroenterol. 2006 Jul;40(6):467-75. doi: 10.1097/00004836-200607000-00003.
Inflammatory bowel diseases are associated with extraintestinal manifestations involving almost every organ system in the body. They occur in approximately 20% to 40% of patients with inflammatory bowel diseases. Immune-related and genetic mechanisms play an important role in the pathogenesis of these complications. Peripheral arthritis, erythema nodosum, and episcleritis respond to the treatment of the underlying intestinal inflammation, whereas axial arthropathy, pyoderma gangrenosum, and uveitis do not. Immunomodulator therapy, particularly with biologic agents has been shown to be effective in treating some of the extraintestinal manifestations. Early recognition and treatment are crucial in preventing major morbidity.
炎症性肠病与累及身体几乎每个器官系统的肠外表现相关。它们发生在约20%至40%的炎症性肠病患者中。免疫相关和遗传机制在这些并发症的发病机制中起重要作用。外周关节炎、结节性红斑和巩膜外层炎对潜在肠道炎症的治疗有反应,而轴性关节病、坏疽性脓皮病和葡萄膜炎则无反应。免疫调节剂治疗,特别是生物制剂治疗,已被证明对治疗某些肠外表现有效。早期识别和治疗对预防严重发病至关重要。